A concise and fully selective synthesis of the ant venom alkaloid (3S,5R,8S,9S)-3-butyl-5-propyl-8-hydroxyindolizidine by Lin, Geng-Jie et al.
PAPER www.rsc.org/obc | Organic & Biomolecular Chemistry
A concise and fully selective synthesis of the ant venom alkaloid
(3S,5R,8S,9S)-3-butyl-5-propyl-8-hydroxyindolizidine†
Geng-Jie Lina and Pei-Qiang Huang*a,b
Received 22nd June 2009, Accepted 23rd July 2009
First published as an Advance Article on the web 24th August 2009
DOI: 10.1039/b912190k
A seven-step synthesis of (3S,5R,8S,9S)-3-butyl-5-propyl-8-hydroxyindolizidine (2), an ant venom
alkaloid isolated from Myrmicaria melanogaster, is disclosed with an overall yield of 28.9%. The key
feature of the synthesis is the use of the iodocyclization for the introduction of the hydroxyl group of
the 3-piperidinol. Remarkably, all the reaction steps proceeded with excellent chemo-, regio- and/or
diastereoselectivities.
Introduction
Nitrogen-containing heterocycles are typical components found
in the venoms of ants of the subfamily Myrmicinae, genera Mega-
lomyrmex, Monomorium and Solenopsis.1 3,5-Dialkylindolizidines
(e.g. 1, monomorine I)2 are one of the earliest reported structural
classes of these compounds (Fig. 1). 3,5-Dialkylindolizidines,
in addition to 2,5-disubstituted pyrrolidines, 3,5-disubstituted
pyrrolizidines and 2,6-disubstituted piperidines, are also often
found among the skin alkaloids of dendrobatid frogs, and oc-
casionally occur in other amphibians.3 Recently, (3S,5R,8S,9S)-3-
butyl-5-propyl-8-hydroxyindolizidine (2) was isolated from Myr-
micaria melanogaster (Emery), a species reported only in Borneo
and collected in the sultanate of Brunei Darussalam.4 The
structure was established by comparison with authentic samples
obtained by a non-stereoselective synthesis. Vapour phase infrared
analysis revealed the Bohlmann bands and an intramolecular
hydrogen bond that allowed the assignment of the relative
stereochemistry. Soon after its isolation, the first enantioselective
synthesis of 2 was reported, which allowed the determination
of its absolute configuration.5 This is the first reported ring-
hydroxylated acetate-derived ant venom alkaloid. Although the
bioactivity of this indolizidine alkaloid has not yet been studied, it
has been reported to be involved in ant warfare. In addition, since
the stereochemistry of 2 is the same as that of the major alkaloid
Fig. 1 The structure of 3,5-dialkylindolizidine alkaloids.
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5Z,9Z-223AB isomer (3) present in Myrmicaria melanogaster,6
its isolation has allowed the advance of a biogenetic relationship
between the mono- and bicyclic ring systems. In continuation
of our general interest in the asymmetric synthesis of bioactive
alkaloids,7 we now report a concise enantioselective synthesis
of 2.
In our retrosynthetic analysis, the piperidine ring was projected
to be built by the intramolecular reductive alkylation8 of 11. The
hydroxyl group was envisioned to be introduced by halonium-
initiated cyclization9 of allylic urethane 8. The latter can be
prepared, in turn, from known N-Boc-(S)-pyroglutamate 4 via
Martin’s cis-diastereoselective reductive alkylation method.10
The synthesis started from known N-Boc-(S)-pyroglutamate
4, which is both commercially available and easily synthesized
from (S)-pyroglutamic acid.11 Treatment of imide 4 with n-butyl
magnesium bromide at -78 ◦C gave the desired keto urethane ester
5 chemoselectively,12 which was then subjected to an intramolecu-
lar reductive carbamoylation under Martin’s conditions10 to give
2,5-disubstituted pyrrolidine derivative 6 as the only observable
isomer in 82% yield from 4 (Scheme 1). It is worthy of mention that
B(C6F5)3 is a milder Lewis acid than BF3·OEt2, which can promote
the reductive alkylation without concomitant cleavage of the
tert-butyl urethane moiety. Regarding the stereochemistry of the
product, the rotamerism of the product prevented determination
of the stereochemistry by NOE experiments. It was assumed to
Scheme 1 The synthesis of allylic urethane 8.































































be cis by analogy with literature precedents,5,8d,10 and confirmed
by a X-ray diffraction analysis of an advanced intermediate (com-
pound 10).
The treatment of 6 with diisobutyl aluminum hydride (DIBAL-
H) in Et2O at -78 ◦C allowed chemoselective reduction of the
ester group to provide the corresponding aldehyde, which was
subjected to a Wittig reaction with an ylide, in situ-generated
from phosphonium 7 and KHMDS. This one-pot transformation
afforded (Z)-olefin 8 as the sole stereoisomer in 72% overall yield.
Due to rotamerism, measuring the coupling constant accurately
was not possible. However, the coupling constant range of <14 Hz
is an indication of a Z-geometry, which could also be deduced by
analogy with literature precedents.8c,13
Now, the stage was set for the key electrophile-mediated
heterocyclization.9,14 Iodocyclization of allylic urethane 8 with
I2 proceeded smoothly in acetonitrile at 0 ◦C to produce iodo-
oxazolidone 9 as the sole regio- and diastereomer in 70% yield
(Scheme 2).
Scheme 2 The I2-mediated iodocyclization of allylic urethane 8.
The structure of compound 9 was assigned on the basis of NMR
experiments. Firstly, the characteristic resonance of the carbon
bound to iodine at high field (dC = 25.7) allowed an unambiguous
localization of the carbon (C–I). Secondly, the HSQC correlation
clearly distinguished the protons Hb (dH = 4.21) with Hc (dH =
4.26). Further inspection of the 1H NMR spectrum of 9 showed a
splitting of a doublet of doublets for Hb and a doublet of doublet
of doublets for Hc. Thus, five membered oxazolidone 9 was formed
instead of its regioisomer 9a. Thus the oxygen–carbon bond was
formed from 8 in a highly regio- and diastereoselective manner.
The observed diastereospecificity in the formation of compound
9 is in agreement with literature precedents,9,14 and may result
from an A(1,3) strain-controlled15 facial differentiation of the alkene.
As shown in Fig. 2, the stereoselectivity of the reaction can be
rationalized on the basis of favored conformer A, which avoids the
Fig. 2 The stereochemical course of I2-mediated iodocyclization.
A(1,3) strain between the pyrrolidine moiety and the bulky carbon
side chain R, as shown in conformer B. The iodine then approaches
the less hindered b-face of the C=C double bond in A to form an
iodonium ion intermediate. Subsequent attack by the carbonyl
oxygen in a 5-exo-trig16 fashion then gives oxazolidone 9.
The radical-initiated reduction (n-Bu3SnH, AIBN, toluene,
reflux) of 9 then afforded oxazolidone 10 in 90% yield (Scheme 3).
The stereochemistry of 10 was confirmed by single-crystal X-ray
diffraction analysis (Fig. 3). By refluxing 10 with Ba(OH)2 in
dioxane and water, the oxazolidone ring was smoothly hydrolyzed
to give amino alcohol 11 in 95% yield. Re-protection of the amine
group (CbzCl, NaHCO3, CH2Cl2, H2O), followed by hydrolysis of
the ketal (p-TsOH, H2O, acetone) and a subsequent Pd(OH)2-
catalyzed reductive amination (H2, 1 atm), produced desired
indolizidine 2. Alternatively a one-pot reaction was achieved
by the subjection of pyrrolidine derivative 11 to hydrogenolysis
conditions in the presence of 1% HCl (10% Pd/C, 1% HCl, H2,
1 atm, rt, 3 d), which provided 2 in 82% yield as the sole
diastereomer. The physical and spectral data of our synthetic
product are in agreement with that reported for the natural
product4,5 {[a]24D -47.8 (c 0.84 in CHCl3); lit.5 [a]24D -48.92 (c 0.62
in CHCl3)}.
Scheme 3 The synthesis of indolizidine alkaloid (3S,5R,8S,9S)-2.
Fig. 3 The X-ray crystal structure of compound 10.
Conclusions
In summary, starting from known (S)-pyroglutamate derivative
4, a concise seven-step synthesis of hydroxylated indolizidine
alkaloid 2 was achieved with an overall yield of 28.9%. It
is noteworthy that all the reactions progressed with excellent
chemo-, regio- and/or diastereoselectivities. To the best of our
knowledge, while electrophile-mediated heterocyclization is a
popular methodology for the synthesis of heterocycles, its use in































































the stereoselective installation of a 3-piperidinol hydroxyl group
is rare.17 We believe that this powerful and highly regio- and
diastereoselective reaction will find applications in the synthesis
of other 3-piperidinol-containing alkaloids.18
Experimental
General
Melting points were determined on a Yanaco MP-500 micro melt-
ing point apparatus and were uncorrected. Infrared spectra were
measured with a Nicolet Avatar 360 FT-IR spectrometer using
film KBr pellet techniques. 1H NMR spectra were recorded in
CDCl3 on a Bruker 400 spectrometer with tetramethylsilane as an
internal standard. Chemical shifts are expressed in d (ppm) units
downfield from TMS. 13C NMR spectra were determined at
100 MHz. Mass spectra were recorded on a Bruker Dalton ESquire
3000 Plus liquid chromatography–mass spectrum (direct injection)
instrument. HRMS spectra were recorded on a Shimadzu LCMS-
IT-TOF apparatus. Optical rotations were measured with a Perkin-
Elmer 341 automatic polarimeter. Silica gel (300-400 mesh) was
used for flash column chromatography, eluting (unless otherwise
stated) with an ethyl acetate/petroleum ether (PE) (60–90 ◦C)
mixture. Diethyl ether and THF were distilled over sodium
benzophenone ketyl under N2. Dichloromethane was distilled over
calcium hydride under N2.
(2S)-1-tert-Butoxycarbonylamino-5-oxononanoic acid methyl ester
(5)
To a cooled solution (-78 ◦C) of compound 4 (2.00 g, 8.23 mmol)
in anhydrous THF (65 mL) was added a solution of n-BuMgBr
(16.5 mmol, 33 mL, 0.5 M) in THF. The mixture was stirred for
3.5 h at -78 ◦C and then quenched with a saturated NH4Cl solution
(20 mL). The reaction mixture was poured into a mixture of H2O
(150 mL) and Et2O (50 mL). The aqueous layer was extracted with
Et2O (3 ¥ 50 mL). The combined organic layers were washed with
brine, dried over anhydrous Na2SO4, filtered and concentrated
under a reduced pressure. Flash column chromatography of the
residue (EtOAc : PE = 1 : 7) afforded product 5 (2.20 g, 90%) as
a colorless oil. [a]24D +8.5 (c 1.93 of CHCl3). [a]24D +4.7 (c 1.39 of
CH2Cl2). [a]24D -16.9 (c 2.32 of CH3CN). nmax/cm-1: 3369, 2959,
2934, 2873, 1745, 1715, 1513, 1438, 1367, 1250, 1213, 1167, 1050
and 1026. dH (CD3CN): 0.85 (3H, s), 1.20–1.30 (2H, m), 1.37
(9H, s), 1.40–1.51 (2H, m), 1.68–1.80 (1H, m), 1.90–2.02 (1H,
m), 2.36 (2H, t, J = 7.4 Hz), 2.40–2.57 (2H, m), 3.63 (3H, s),
4.00–4.10 (1H, m) and 5.55–5.65 (1H, m). dC (CD3CN): 14.7,
23.5, 26.9, 27.1, 29.1, 39.4, 43.5, 53.2, 54.4, 80.4, 157.0, 174.4 and
211.3. MS (ESI): m/z 324 [M + Na+, 100%]. Found: C, 59.56;




A CH2Cl2 (15 mL) solution of B(C6F5)3 (645 mg, 1.26 mmol) was
added to a CH2Cl2 (20 mL) solution of Ph3SiH (5.22 g, 20.1 mmol)
at room temperature. The solution was stirred for 10 min and
then transferred to a stirred solution of compound 5 (2.00 g,
6.64 mmol) at -78 ◦C. The mixture was allowed to slowly warm
to room temperature and stirred for a further 2 d. A saturated
aqueous solution of NaHCO3 (15 mL) was added, the organic
layer was separated and the aqueous layer extracted with CH2Cl2
(3 ¥ 40 mL). The combined organic layers were washed with brine,
dried over anhydrous Na2SO4, filtered and concentrated under a
reduced pressure. Flash column chromatography of the residue
(EtOAc : PE = 1 : 10) gave compound 6 (1.630 g, 86%) as a
colorless oil. [a]24D -22.5 (c 0.97 of CHCl3). nmax/cm-1: 2956, 2922,
2873, 1755, 1702, 1455, 1431, 1392, 1366, 1282, 1257, 1202, 1169,
1127, 1105 and 1033. dH (DMSO-d6 at 343 K): 0.88 (3H, t, J =
7.1 Hz), 1.22–1.35 (5H, m), 1.36 (9H, s), 1.60–1.70 (1H, m), 1.72–
1.81 (1H, m), 1.81–1.86 (1H, m), 1.86–1.96 (1H, m), 2.11–2.19 (1H,
m), 3.63 (3H, s), 3.70–3.78 (1H, m) and 4.17 (1H, t, J = 7.8 Hz).
dC (DMSO-d6 at 343 K): 13.5, 21.7, 27.7, 27.8, 27.9, 33.2, 51.2,
57.8, 59.2, 78.4, 152.9 and 172.8. MS (ESI): m/z 308 [M + Na+,
100%]. Found: C, 63.23; H, 9.51; N, 4.91. Calc. for C15H27NO4: C,
63.13; H, 9.54; N, 4.91%.
tert-Butyl-(2S,5S)-2-butyl-5-[(Z)-3-(2-propyl-1,3-dioxolan-2-
yl)prop-1-enyl]pyrrolidine-1-carboxylate (8)
A solution of DIBAL-H (1.0 M in toluene, 6.2 mL, 6.2 mmol)
was added dropwise over 30 min to a solution of compound 6
(960 mg, 3.37 mmol) in toluene (20 mL) at -78 ◦C. After stirring
for 10 min, Et2O (30 mL), H2O (12 mL) and 15% NaOH (18 mL)
were added successively, and the resultant mixture was stirred at
room temperature for 30 min. The reaction mixture was extracted
with Et2O (3 ¥ 40 mL). The organic layers were washed with
brine, dried over anhydrous Na2SO4, filtered and evaporated to
dryness under a reduced pressure. The residue was dissolved in
THF (5 mL) and added at 0 ◦C to a pre-prepared solution of
phosphonium 7 (4.616 g, 9.53 mmol) and KHMDS (0.5 M in
toluene, 9.50 mmol, 19 mL) in THF (20 mL) that had been stirred
at 0 ◦C for 1 h. The mixture was allowed to warm to room
temperature and stirred overnight. The reaction was quenched
with a saturated NH4Cl solution (20 mL) and the mixture extracted
with EtOAc (3 ¥ 30 mL). The filtrate was washed with brine, dried
over anhydrous Na2SO4, filtered and concentrated under a reduced
pressure. Flash column chromatography of the residue (EtOAc :
PE = 1 : 10) gave compound 8 (911 mg, 71%) as a colorless oil.
[a]24D +107.4 (c 1.26 of CHCl3). nmax/cm-1: 2959, 2926, 2874, 1753,
1694, 1454, 1387, 1365, 1255, 1170 and 1103. dH: 0.90 (3H, t,
J = 6.5 Hz), 0.91 (3H, t, J = 7.4 Hz), 1.20–1.50 (7H, m), 1.42
(9H, s), 1.55–1.70 (4H, m), 1.70–1.95 (2H, m), 2.00–2.10 (1H, m),
2.28–2.45 (1H, m), 2.50–2.62 (1H, m), 3.75–3.85 (1H, m), 3.88–
3.99 (4H, m), 4.43–4.46 (1H, m) and 5.03–5.05 (2H, m). dC: 14.3,
14.5, 17.0, 22.9, 28.8, 29.0, 29.5, 31.6, 35.5, 35.9, 40.1, 55.6, 58.9,
65.2, 65.3, 79.1, 111.6, 123.0–124.0 (br s), 136.0–136.4 (br s) and
155.0. MS (ESI): m/z 404 [M + Na+, 100%]. Found: C, 69.44;




To a vigorously stirred solution of compound 8 (850 mg,
2.23 mmol) in CH3CN at 0 ◦C (5.5 mL) was added fine
powdered NaHCO3 (756 mg, 9.00 mmol) together with I2 (1.143 g,
4.50 mmol). The resulting mixture was stirred at 0 ◦C for 1 h. A































































saturated aqueous solution of Na2S2O3 (5 mL) was added and
the mixture stirred for 10 min. The aqueous layer was separated
and extracted with diethyl ether (3 ¥ 20 mL). The combined
organic extracts were washed with brine, dried over anhydrous
Na2SO4, filtered and concentrated under a reduced pressure. Flash
column chromatography of the residue (EtOAc : PE = 1 : 2) gave
compound 9 (704 mg, 70%) as a colorless oil. [a]24D +8.6 (c 1.11
of CHCl3). nmax/cm-1: 2958, 2929, 2873, 1756, 1465, 1406, 1378,
1259, 1167 and 1055. dH: 0.91 (3H, t, J = 7.1 Hz), 0.92 (3H, t,
J = 7.3 Hz), 1.22–1.50 (7H, m), 1.58–1.72 (3H, m), 1.87–1.95
(1H, m), 2.02–2.12 (1H, m), 2.12–2.21 (1H, m), 2.29–2.39 (1H,
m), 2.36 (1H, dd, J = 7.0 and 15.5 Hz), 2.45 (1H, dd, J = 5.3
and 15.5 Hz), 3.50–3.58 (1H, m), 3.86 (1H, ddd, J = 6.0, 7.1 and
9.2 Hz), 3.91–4.02 (4H, m), 4.21 (1H, dd, J = 3.4 and 7.1 Hz)
and 4.26 (1H, ddd, J = 3.4, 5.3 and 7.0 Hz). dC: 14.2, 14.4, 17.1,
22.8, 25.9, 29.0, 29.9, 30.0, 33.1, 39.9, 41.3, 57.0, 64.9, 65.0, 65.8,
83.1, 110.9 and 155.4. MS (ESI): m/z 474 [M + Na+, 100%].




To a solution of compound 9 (660 mg, 1.46 mmol) and AIBN
(35 mg, 0.22 mmol) in toluene (20 mL) was added tributyltin
hydride (2.130 g, 7.3 mmol). The resulting mixture was refluxed
under an atmosphere of nitrogen overnight. After cooling to room
temperature, the solvent was evaporated under a reduced pressure.
Flash column chromatography of the residue (EtOAc : PE = 1 : 3)
gave compound 10 (465 mg, 98%) as white crystals. mp 86–87 ◦C
(EtOAc/PE). [a]24D -3.1 (c 0.93 of CHCl3). nmax/cm-1: 2958, 2929,
2874, 1753, 1465, 1404, 1367, 1263 and 1071. dH: 0.91 (3H, t, J =
7.1 Hz), 0.92 (3H, t, J = 7.3 Hz), 1.20–1.47 (7H, m), 1.53–1.68
(4H, m), 1.70–1.96 (5H, m), 2.09–2.22 (1H, m), 2.23–2.34 (1H,
m), 3.47–3.55 (1H, m), 3.74 (1H, ddd, J = 5.6, 8.2 and 9.1 Hz),
3.90–3.97 (4H, m) and 4.18 (1H, dt, J = 5.6 and 7.7 Hz). dC: 14.2,
14.5, 17.3, 22.8, 28.6, 28.7, 29.0, 30.4, 32.4, 33.6, 39.7, 56.5, 65.2
(2C), 66.6, 82.3, 111.2 and 156.1. MS (ESI): m/z 348 [M + Na+,
100%]. Found: C, 66.37; H, 9.58; N, 4.31. Calc. for C18H31NO4: C,
66.43; H, 9.60; N, 4.30%.
(2S,5S)-2-Butyl-5-[(S)-1-hydroxy-3-(2-propyl-1,3-dioxolan-2-
yl)propyl]pyrrolidine (11)
A suspension of Ba(OH)2·8H2O (2.465 g, 7.80 mmol) in H2O
(40 mL) was added in one portion to a solution of 10 (420 mg,
1.30 mmol) in 1,4-dioxane (60 mL). The resulting mixture was
refluxed for 48 h at 120 ◦C. After cooling to room temperature, the
precipitated inorganic salts were filtered off through a glass frit and
washed with MeOH (3 ¥ 10 mL). The solution was concentrated
under a reduced pressure. Flash column chromatography of the
residue (CH3OH : CH2Cl2 : NH3·H2O = 10 : 100 : 1) gave
compound 11 (361 mg, 93%) as a pale yellow oil. [a]24D -14.0 (c
0.77 of CHCl3). nmax/cm-1: 3354, 2957, 2931, 2873, 1530, 1466,
1407, 1195 and 1075. dH: 0.89 (3H, t, J = 7.1 Hz), 0.91 (3H, t, J =
7.3 Hz), 1.20–1.54 (11H, m), 1.54–1.70 (4H, m), 1.75–1.95 (3H,
m), 2.90–3.14 (4H, m), 3.21 (1H, ddd, J = 3.5, 5.8 and 9.0 Hz) and
3.92–3.96 (4H, m). dC: 14.3, 14.6, 17.3, 23.0, 28.6, 29.7, 30.0, 31.5,
33.6, 36.9, 39.6, 59.2, 62.6, 65.0, 65.1, 73.9 and 111.9. MS (ESI):
m/z 300 [M + H+, 100%]. HRMS (ESI) calc. for C17H34NO3 [M +
H+]: 300.2533; found: 300.2549.
(2S,5S)-Benzyl-2-butyl-5-[(S)-1-hydroxy-3-(2-propyl-1,3-
dioxolan-2-yl)propyl]pyrrolidine-1-carboxylate (12)
A mixture of compound 11 (200 mg, 0.67 mmol) and CbzCl
(0.70 mmol) in CH2Cl2/H2O (10/10 mL) was stirred in the
presence of NaHCO3 (2.0 mmol, 170 mg) for 2 h. The organic
layer was separated and the aqueous layer extracted with CH2Cl2
(3 ¥ 10 mL). The combined organic layers were washed with brine,
dried over anhydrous Na2SO4, filtered and concentrated under a
reduced pressure. Flash column chromatography of the residue
(EtOAc : PE = 1 : 1) gave compound 12 (258 mg, 89%) as a
colorless oil. [a]24D -31.9 (c 1.27 of CHCl3). nmax/cm-1: 3441, 2958,
2930, 2873, 1697, 1669, 1498, 1453, 1412, 1352, 1306, 1190 and
1099. dH: 0.84 (3H, t, J = 6.8 Hz), 0.91 (3H, t, J = 7.3 Hz), 1.18–
1.45 (8H, m), 1.53–1.75 (7H, m), 1.80–2.03 (3H, m), 3.46 (1H, dt,
J = 2.4 and 8.7 Hz), 3.80–3.90 (1H, m), 3.92 (4H, s, overlapped),
3.90–4.01 (1H, m, overlapped), 5.10 (1H, d, J = 12.4 Hz), 5.19
(1H, d, J = 12.4 Hz) and 7.28–7.38 (5H, m). dC: 14.1, 14.6, 17.3,
22.7, 27.4, 28.7, 29.0, 29.7, 32.6, 35.3, 39.6, 59.4, 64.4, 65.0 (2C),
67.6, 111.9, 128.1, 128.2, 128.6 and 136.6. MS (ESI): m/z 456 [M +
Na+, 100%]. Anal. calc. for C25H39NO5: C, 69.25; H, 9.07; N, 3.23.
Found: C, 69.14; H, 9.05; N, 3.23%.
(3S,5R,8S,9S)-3-Butyl-5-propyl-8-hydroxyindolizidine (2)
Preparation via compound 12. A solution of compound 12
(96 mg, 0.22 mmol) in acetone/H2O (15 : 1, 5 mL) containing
TsOH·H2O (30 mg) was stirred at room temperature for 1 d. The
mixture was diluted with water (20 mL) and extracted with CH2Cl2
(3 ¥ 20 mL). The combined organic layers were washed with brine,
dried over anhydrous Na2SO4 and concentrated under a reduced
pressure. To the residue were added EtOH (10 mL) and 20%
Pd(OH)2 (20 mg). The resulting suspension was hydrogenated at 1
atm for 24 h. The catalyst was filtered off, washed with MeOH (3 ¥
10 mL) and the filtrate evaporated. Flash column chromatography
of the residue (CH3OH : CH2Cl2 : NH3·H2O = 20 : 100 : 1) gave
compound 2 (45 mg, 86%) as a pale yellow oil.
Direct preparation from compound 11. In the presence of HCl
(1M in H2O, 0.05 mL) and a catalytic amount of Pearlman’s cat-
alyst (20% Pd(OH)2/C, 10 mg), compound 11 (30 mg, 0.1 mmol)
in ethanol (5 mL) was hydrogenated under an atmosphere of
hydrogen for 3 d. The catalyst was filtered off, washed with
MeOH (3 ¥ 10 mL) and the filtrate evaporated. Flash column
chromatography of the residue (CH3OH : CH2Cl2 : NH3·H2O =
20 : 100 : 1) gave compound 2 (19 mg, 82%) as a pale yellow oil.
[a]24D -47.8 (c 0.84 of CHCl3) {lit.5 [a]24D -48.92 (c 0.62 of CHCl3)}.
nmax/cm-1: 3483, 2957, 2933, 2872, 2855, 1465, 1446, 1403, 1378,
1313, 1199, 1130, 1107, 1088 and 1054. dH: 0.90 (3H, t, J = 7.2 Hz),
0.92 (3H, t, J = 7.3 Hz), 1.14–1.53 (12H, m), 1.54–1.66 (3H, m),
1.68–1.88 (3H, m), 2.27 (1H, apparent t, J = 9.7 Hz, NCH), 2.42
(1H, dd, J = 4.5 and 10.7 Hz, NCH), 2.76 (1H, apparent t, J =
8.1 Hz, NCH), 3.05 (1H, br, D2O exchangeable, OH) and 3.75
(1H, br, CHOH). dC: 14.3, 14.6, 19.3, 23.1, 26.0, 26.7, 28.9, 29.1,
32.3, 37.9, 39.5, 60.7, 64.4, 65.6 and 70.4. MS (ESI): m/z 240 [M +
H+, 100%]. HRMS (ESI) calc. for C15H30NO [M + H+]: 240.2322;
found: 240.2330.
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